Chambre de patient : Questions médicales fréquentes
Nom anglais: Patients' Rooms
Descriptor UI:D010362
Tree Number:N02.278.220.640
Termes MeSH sélectionnés :
Cell Engineering
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chambre de patient : Questions médicales les plus fréquentes",
"headline": "Chambre de patient : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chambre de patient : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-14",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chambre de patient"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Établissements de santé",
"url": "https://questionsmedicales.fr/mesh/D006268",
"about": {
"@type": "MedicalCondition",
"name": "Établissements de santé",
"code": {
"@type": "MedicalCode",
"code": "D006268",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N02.278"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chambre de patient",
"alternateName": "Patients' Rooms",
"code": {
"@type": "MedicalCode",
"code": "D010362",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Erwin Ista",
"url": "https://questionsmedicales.fr/author/Erwin%20Ista",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, section Nursing Science, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands."
}
},
{
"@type": "Person",
"name": "Monique van Dijk",
"url": "https://questionsmedicales.fr/author/Monique%20van%20Dijk",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, section Nursing Science, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands."
}
},
{
"@type": "Person",
"name": "Melinda Wang",
"url": "https://questionsmedicales.fr/author/Melinda%20Wang",
"affiliation": {
"@type": "Organization",
"name": "From the Yale School of Medicine."
}
},
{
"@type": "Person",
"name": "Barbara Banda",
"url": "https://questionsmedicales.fr/author/Barbara%20Banda",
"affiliation": {
"@type": "Organization",
"name": "VA Connecticut Healthcare System, West Haven, Connecticut."
}
},
{
"@type": "Person",
"name": "Naseema B Merchant",
"url": "https://questionsmedicales.fr/author/Naseema%20B%20Merchant",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Integrating Micro and Nano Technologies for Cell Engineering and Analysis: Toward the Next Generation of Cell Therapy Workflows.",
"datePublished": "2022-09-26",
"url": "https://questionsmedicales.fr/article/36154011",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsnano.2c05494"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent Advances in DNA-Based Cell Surface Engineering for Biological Applications.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/35977912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/chem.202202070"
}
},
{
"@type": "ScholarlyArticle",
"name": "Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering.",
"datePublished": "2023-02-23",
"url": "https://questionsmedicales.fr/article/36828738",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcyt.2023.01.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Survival advantage of native and engineered T cells is acquired by mitochondrial transfer from mesenchymal stem cells.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39334383",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-024-05627-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Highly efficient mRNA delivery with nonlinear microfluidic cell stretching for cellular engineering.",
"datePublished": "2023-03-28",
"url": "https://questionsmedicales.fr/article/36727443",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2lc01115h"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Établissements, main d'oeuvre et services de soins de santé",
"item": "https://questionsmedicales.fr/mesh/D005159"
},
{
"@type": "ListItem",
"position": 3,
"name": "Établissements de santé",
"item": "https://questionsmedicales.fr/mesh/D006268"
},
{
"@type": "ListItem",
"position": 4,
"name": "Chambre de patient",
"item": "https://questionsmedicales.fr/mesh/D010362"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chambre de patient - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chambre de patient",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chambre de patient",
"description": "Comment évaluer l'état d'un patient en chambre ?\nQuels outils sont utilisés pour le diagnostic en chambre ?\nComment surveiller un patient en chambre ?\nQuelles sont les méthodes de diagnostic en chambre ?\nQuel rôle joue l'infirmière dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Cell+Engineering&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chambre de patient",
"description": "Quels symptômes peuvent nécessiter une hospitalisation ?\nComment les symptômes sont-ils surveillés en chambre ?\nQuels symptômes indiquent une détérioration ?\nComment signaler des symptômes nouveaux ?\nQuels symptômes nécessitent une intervention rapide ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Cell+Engineering&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chambre de patient",
"description": "Comment prévenir les infections en chambre ?\nQuelles sont les pratiques de prévention des chutes ?\nComment prévenir les escarres en chambre ?\nQuel rôle joue l'éducation des patients dans la prévention ?\nComment prévenir les erreurs médicamenteuses ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Cell+Engineering&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chambre de patient",
"description": "Quels traitements sont administrés en chambre ?\nComment les traitements sont-ils ajustés ?\nQuel est le rôle des protocoles de traitement ?\nComment les effets secondaires des traitements sont-ils gérés ?\nQuels traitements sont courants pour les infections ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Cell+Engineering&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chambre de patient",
"description": "Quelles complications peuvent survenir en chambre ?\nComment gérer les complications en chambre ?\nQuels signes indiquent une complication ?\nComment prévenir les complications post-opératoires ?\nQuel est l'impact des complications sur le séjour ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Cell+Engineering&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chambre de patient",
"description": "Quels facteurs de risque influencent l'hospitalisation ?\nComment les antécédents médicaux affectent-ils le séjour ?\nQuel rôle joue l'environnement dans le risque d'infection ?\nComment le stress affecte-t-il la santé en chambre ?\nQuels comportements augmentent le risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Cell+Engineering&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'état d'un patient en chambre ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des examens cliniques et des tests diagnostiques."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic en chambre ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des appareils comme les moniteurs de signes vitaux et les échographes sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment surveiller un patient en chambre ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance inclut le suivi des paramètres vitaux et l'observation des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles sont les méthodes de diagnostic en chambre ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les méthodes incluent l'imagerie, les analyses de sang et les examens physiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'infirmière dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infirmière collecte des données et aide à interpréter les résultats des tests."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent nécessiter une hospitalisation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme la douleur intense, la fièvre élevée ou la confusion."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils surveillés en chambre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont surveillés par des évaluations régulières et des rapports d'infirmières."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une détérioration ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une détérioration peut se manifester par une aggravation de la douleur ou des signes vitaux anormaux."
}
},
{
"@type": "Question",
"name": "Comment signaler des symptômes nouveaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients doivent informer le personnel soignant immédiatement de tout changement."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une intervention rapide ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'essoufflement ou la perte de conscience nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections en chambre ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures d'hygiène strictes et l'utilisation d'équipements de protection sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles sont les pratiques de prévention des chutes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les pratiques incluent l'évaluation des risques et l'utilisation de dispositifs d'assistance."
}
},
{
"@type": "Question",
"name": "Comment prévenir les escarres en chambre ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le repositionnement régulier et l'utilisation de matelas spéciaux aident à prévenir les escarres."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation des patients dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation aide les patients à comprendre les risques et à participer activement à leur soin."
}
},
{
"@type": "Question",
"name": "Comment prévenir les erreurs médicamenteuses ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vérifications systématiques et des protocoles de double vérification sont mis en place."
}
},
{
"@type": "Question",
"name": "Quels traitements sont administrés en chambre ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des perfusions et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils ajustés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont ajustés en fonction de la réponse du patient et des résultats des tests."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des protocoles de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les protocoles guident les soins et assurent la cohérence dans l'administration des traitements."
}
},
{
"@type": "Question",
"name": "Comment les effets secondaires des traitements sont-ils gérés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont surveillés et gérés par des ajustements de dosage ou des médicaments supplémentaires."
}
},
{
"@type": "Question",
"name": "Quels traitements sont courants pour les infections ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections sont souvent traitées avec des antibiotiques et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir en chambre ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les infections, les thromboses et les réactions aux médicaments."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications en chambre ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique une surveillance étroite et des interventions médicales appropriées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une douleur accrue, une fièvre persistante ou des changements de comportement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications post-opératoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut des soins appropriés, une surveillance et une mobilisation précoce."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des complications sur le séjour ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent prolonger le séjour hospitalier et augmenter les coûts de soins."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent l'hospitalisation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, les comorbidités et le mode de vie augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux affectent-ils le séjour ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux peuvent influencer le traitement et le risque de complications."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'environnement dans le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement non stérile augmente le risque d'infections nosocomiales."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il la santé en chambre ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut aggraver les symptômes et retarder la guérison des patients."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de complications ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements comme le tabagisme et la sédentarité augmentent le risque de complications."
}
}
]
}
]
}
The emerging field of cell therapy offers the potential to treat and even cure a diverse array of diseases for which existing interventions are inadequate. Recent advances in micro and nanotechnology ...
Due to its excellent programmability and biocompatibility, DNA molecule has unique advantages in cell surface engineering. Recent progresses provide a reliable and feasible way to engineer cell surfac...
Most current chimeric antigen receptor (CAR) T cells are generated by viral transduction, which induces persistent expression of CARs and may cause serious undesirable effects. Messenger RNA (mRNA)-ba...
The authors designed and engineered an exosome delivery platform using the bacteriophage MS2 system in combination with the highly expressed protein lysosome-associated membrane protein 2 isoform B on...
The authors' delivery platform achieved specific loading and delivery of mRNA into target cells and achieved expression of specific proteins, and anti-CD3/CD28 single-chain variable fragments (scFvs) ...
The delivery of CAR mRNA and anti-CD3/CD28 scFvs via designed exosomes can be used for ex vivo production of CAR T cells with cancer cell killing capacity. The authors' results indicate the potential ...
Apoptosis, a form of programmed cell death, is critical for the development and homeostasis of the immune system. Chimeric antigen receptor T (CAR-T) cell therapy, approved for hematologic cancers, re...
We used a cell-free approach using artificial MitoT (Mitoception) of UC-MSC derived MT to peripheral blood mononuclear cells (PBMCs) followed by RNA-seq analysis of CD3...
Gene expression related to apoptosis, cell death and/or responses to different stimuli was modified in CD3...
Artificial MitoT prevents STS-induced apoptosis of human CD3...
In the past few years, messenger RNA (mRNA) has emerged as a promising therapeutic agent for the treatment and prevention of various diseases. Clinically, mRNA-based drugs have been used for cancer im...
Recent investigations employing animal models have highlighted the significance of microglia as crucial immunological modulators in various neuropsychiatric and physical diseases. Postmortem brain ana...
Colorectal tumours are often densely infiltrated by immune cells that have a role in surveillance and modulation of tumour progression but are burdened by immunosuppressive signals, which might vary f...
We paired high-dimensional flow cytometry, RNA sequencing and immunohistochemistry to describe the functional phenotype of T cells from healthy and neoplastic tissue of patients with primary and metas...
We found that T cells are mainly localised at the front edge and that tumor-infiltrating T cells co-express multiple inhibitory receptors, which largely differ from primary to metastatic sites. Our da...
HER-2-specific CD39 disrupted engineered T cells are promising advanced medicinal products for primary and metastatic CRC....
Optimization of cell engineering protocols requires standard, comprehensive quality metrics. We previously developed CellNet, a computational tool to quantitatively assess the transcriptional fidelity...
Manipulation of cells for applications such as biomanufacturing and cell-based therapeutics involves introducing biomolecular cargoes into cells. However, successful delivery is a function of multiple...
The programmed cell death protein 1 (PD-1) signaling pathway is a major source of dampened T cell activity in the tumor microenvironment. While clinical approaches to inhibiting the PD-1 pathway using...